Nagafuku, N. | bioRxiv Science

bioRxiv2025

Field potential Imaging in human iPSC- derived Cardiomyocytes using UHD-CMOS-MEA

Evaluation using beat propagation analysis of human iPS cardiomyocytes is an effective approach for assessing human cardiac safety in drug development. However, current applications are primarily focused on detecting QT prolongation and arrhythmia risk, while its ability to comprehensively detect cardiotoxicity remains insufficient. Additionally, predicting the mechanism of action, which is crucial in drug development, remains challenging. In this study, we employed field potential imaging (FPI) using an ultra-high-density (UHD) CMOS microelectrode array (MEA) comprising 236,880 electrodes with high spatiotemporal resolution, capable of recording the activity of a monolayer of cardiomyocytes with tens of electrodes per cell. This method enabled the establishment of novel electrophysiological endpoints, including the number of excitation origins, fluctuations in origin positions, conduction velocity, and propagation area. Pharmacological characterization revealed drug-specific effects: isoproterenol increased excitation origins, mexiletine reduced conduction velocity, and E-4031 decreased propagation area while inducing early afterdepolarizations. Multivariate analysis of 13 compounds across 17 electrophysiological endpoints distinguished conduction velocity and propagation patterns based on their mechanisms of action. Additionally, 0.1 M doxorubicin exposure for 24 hours significantly reduced conduction velocity and propagation area, allowing early detection of chronic cardiotoxicity. These findings suggest that UHD-CMOS-MEA-based FPI enhances cardiotoxicity detection at low concentrations and precisely characterizes ion channel activity across different drug concentrations. The integration of novel electrophysiological endpoints derived from UHD-CMOS-MEA-based FPI, including excitation origin analysis, conduction velocity, and propagation area, along with multivariate analysis, is anticipated to establish a next-generation in vitro platform for comprehensive cardiotoxicity risk assessment and mechanism-based prediction of drug candidates.

pharmacology and toxicology↗

bioRxiv2022

Large-area electrical imaging having single neuron resolution using 236,880 electrodes CMOS-MEA technology

The electrophysiological technology having a high spatio-temporal resolution at the single-cell level, and noninvasive measurements of large areas provides insights on underlying neuronal function. Here, we used a complementary metal-oxide semiconductor (CMOS)-microelectrode array (MEA) that uses 236,880 electrodes each with an electrode size of 11.22 x 11.22 {micro}m and 236,880 covering a wide area of 5.5 x 5.7 mm in presenting a detailed and single-cell-level neural activity analysis platform for brain slices, human iPS cell-derived cortical networks, peripheral neurons, and human brain organoids. Propagation pattern characteristics between brain regions changes the synaptic strength into compounds based on single-cell time-series patterns, classification based on single DRG neuron firing patterns and compound responses, axonal conduction characteristics and changes to anticancer drugs, and network activities and transition to compounds in brain organoids were extracted. This detailed analysis of neural activity at the single-cell level using our CMOS-MEA provides a new understanding the basic mechanisms of brain circuits in vitro and ex vivo, on human neurological diseases for drug discovery, and compound toxicity assessment.

neuroscience↗